Cohance Lifesciences Gears Up for Q3 Reveal on 12th February; Check Key Expectations Here

Posted by : Ekta Dhawan | Wed Feb 11 2026

Click and Sign Up to Get Live Updates on Q3 Results

Cohance Lifesciences ‘s Q3 results FY26 are scheduled to be announced on 12th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Table of Contents

Cohance Lifesciences Q3 Results 2026 Preview

Cohance Lifesciences’ revenue is expected to be in the range of ₹307.15 crore, a 49.13% YoY decrease.
Profit After Tax, or PAT, is projected to fall 40.15% YoY.
Net profit is ₹82.88 crore, a fall 40.15% YoY
EBITDA to fall 41.91%

Cohance Lifesciences Share Performance

Over the past six months, Cohance Lifesciences’ share price has fallen by 62.56% to ₹352.50.
Moreover, over the past year, the stock has decreased by 67.01%.
Despite this weak short-term performance, Cohance Lifesciences’ stock has delivered a financially sound 67.61% return over the past 5 years.
As of 11th February 2026, the stock traded at ₹352.60 per share.

Key Factors to Watch for Cohance Lifesciences Q3 Results FY26

Revenue & Segment Growth: Trends in overall sales and performance across CDMO and API+ businesses.
Profitability & Margins: EBITDA and net profit margins amid cost and operating pressures.
Order Execution & Project Timing: Impact of timing of CDMO project starts and shipments.
Niche Technology Demand: Growth in specialized chemistries like ADCs and oligonucleotides.
Management Outlook: Guidance on FY26 growth trajectory and long-term goals.

Final Thoughts

Cohance Lifesciences will announce its Q3 FY26 results on 12th February 2026. Analysts expect % revenue growth, a 27.3% fall in PAT, and a 18.14% rise in EBITDA. Cohance Lifesciences focuses on revenue growth, margins, order execution, high-value segment performance, and management outlook.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!